In reply to the Letter to the Editor by Chen and Lui regarding "Radiotherapy enhances uptake and efficacy of Y-cetuximab: A preclinical trial" by A Dietrich et al.

Antje Dietrich Michael Andreeff Lydia Koi Ralf Bergmann Maik Schubert Lena Schreiner Steffen Löck Wiebke Sihver Robert Freudenberg Sandra Hering Hans-Jürgen Pietzsch Jörg Steinbach Jörg Kotzerke Michael Baumann Mechthild Krause

Radiother Oncol

German Cancer Consortium (DKTK), Partner Site Dresden, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany; OncoRay National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Helmholtz-Zentrum Dresden - Rossendorf, TU, Dresden, Germany; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TU, Dresden, Germany; Helmholtz-Zentrum Dresden - Rossendorf, Institute of Radiooncology - OncoRay, Dresden, Germany; National Center for Tumor Diseases (NCT), Partner Site Dresden, Germany German Cancer Research Center (DKFZ), Heidelberg, Germany.

Published: August 2021

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.radonc.2021.06.014	DOI Listing

Publication Analysis

Top Keywords

reply letter

letter editor

editor chen

chen lui

lui "radiotherapy

"radiotherapy enhances

enhances uptake

uptake efficacy

efficacy y-cetuximab

y-cetuximab preclinical

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!